Cargando…

Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study

PURPOSE: A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an au...

Descripción completa

Detalles Bibliográficos
Autores principales: Berbee, J. K., Lammers, L. A., Krediet, C. T. P., Fischer, J. C., Kemper, E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662679/
https://www.ncbi.nlm.nih.gov/pubmed/28782093
http://dx.doi.org/10.1007/s00228-017-2311-6
_version_ 1783274680476499968
author Berbee, J. K.
Lammers, L. A.
Krediet, C. T. P.
Fischer, J. C.
Kemper, E. M.
author_facet Berbee, J. K.
Lammers, L. A.
Krediet, C. T. P.
Fischer, J. C.
Kemper, E. M.
author_sort Berbee, J. K.
collection PubMed
description PURPOSE: A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an automatic alert system. METHODS: To investigate the relevance of the interaction of paracetamol and flucloxacillin, a retrospective study was conducted. Data on paracetamol and flucloxacillin prescriptions and laboratory data (pH, Na(+), HCO(3) (−), Cl(−), albumin and 5-oxoproline levels) were combined to assess the prevalence of acidosis, calculate the anion gap and analyse 5-oxoproline levels in clinically admitted patients using both drugs simultaneously. RESULTS: In the 2-year study period, approximately 53,000 admissions took place in our hospital. One thousand and fifty-seven patients used paracetamol and flucloxacillin simultaneously, of which 51 patients (4.8%) had a serum pH ≤ 7.35. One patient, the same patient as presented in the case report, had a high anion gap and a toxic level of 5-oxoproline. CONCLUSION: The prevalence of metabolic acidosis is very low and the only patient identified with the interaction was recognised during normal clinical care. We conclude that automatic alerts based on simultaneous use of paracetamol and flucloxacillin will generate too many signals. To recognise patients earlier and prevent severe outcomes, a warning system (clinical rule) based on paracetamol, flucloxacillin and pH measurement may be helpful. Early calculation of the anion gap can narrow the differential diagnosis of patients with metabolic acidosis and measurement of 5-oxoproline can explain acidosis due the interaction of paracetamol and flucloxacillin. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00228-017-2311-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5662679
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-56626792017-11-15 Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study Berbee, J. K. Lammers, L. A. Krediet, C. T. P. Fischer, J. C. Kemper, E. M. Eur J Clin Pharmacol Pharmacoepidemiology and Prescription PURPOSE: A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an automatic alert system. METHODS: To investigate the relevance of the interaction of paracetamol and flucloxacillin, a retrospective study was conducted. Data on paracetamol and flucloxacillin prescriptions and laboratory data (pH, Na(+), HCO(3) (−), Cl(−), albumin and 5-oxoproline levels) were combined to assess the prevalence of acidosis, calculate the anion gap and analyse 5-oxoproline levels in clinically admitted patients using both drugs simultaneously. RESULTS: In the 2-year study period, approximately 53,000 admissions took place in our hospital. One thousand and fifty-seven patients used paracetamol and flucloxacillin simultaneously, of which 51 patients (4.8%) had a serum pH ≤ 7.35. One patient, the same patient as presented in the case report, had a high anion gap and a toxic level of 5-oxoproline. CONCLUSION: The prevalence of metabolic acidosis is very low and the only patient identified with the interaction was recognised during normal clinical care. We conclude that automatic alerts based on simultaneous use of paracetamol and flucloxacillin will generate too many signals. To recognise patients earlier and prevent severe outcomes, a warning system (clinical rule) based on paracetamol, flucloxacillin and pH measurement may be helpful. Early calculation of the anion gap can narrow the differential diagnosis of patients with metabolic acidosis and measurement of 5-oxoproline can explain acidosis due the interaction of paracetamol and flucloxacillin. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00228-017-2311-6) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-08-07 2017 /pmc/articles/PMC5662679/ /pubmed/28782093 http://dx.doi.org/10.1007/s00228-017-2311-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Pharmacoepidemiology and Prescription
Berbee, J. K.
Lammers, L. A.
Krediet, C. T. P.
Fischer, J. C.
Kemper, E. M.
Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
title Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
title_full Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
title_fullStr Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
title_full_unstemmed Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
title_short Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
title_sort metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? a case report and a retrospective study
topic Pharmacoepidemiology and Prescription
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662679/
https://www.ncbi.nlm.nih.gov/pubmed/28782093
http://dx.doi.org/10.1007/s00228-017-2311-6
work_keys_str_mv AT berbeejk metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy
AT lammersla metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy
AT kredietctp metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy
AT fischerjc metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy
AT kemperem metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy